Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Vibrio cholerae O1 Ogawa O-antigen is a critical surface polysaccharide component of the lipopolysaccharide (LPS) found in the Ogawa serotype of Vibrio cholerae O1, the primary causative agent of epidemic cholera (Chatterjee & Chaudhuri, 2003; https://doi.org/10.1016/S0925-4439(03)00061-1). Structurally, it consists of a homopolymer of alpha(1-2)-linked 4-amino-4-deoxy-D-glycero-D-talo-octonic acid, distinguished from the Inaba serotype by the presence of a 2-O-methyl group on the non-reducing terminal sugar (Villeneuve et al., 2000; https://doi.org/10.1073/pnas.97.15.8433). This antigen plays a vital role in bacterial pathogenesis and is the dominant target for protective vibriocidal antibodies in the human host (Harris et al., 2012; https://doi.org/10.1016/S0140-6736(12)60436-X). Therapeutic strategies primarily involve oral cholera vaccines (OCVs) that utilize inactivated whole cells or purified O-antigen conjugates to elicit mucosal immunity (WHO, 2017; https://www.who.int/publications/i/item/who-wer9234). Monitoring immune responses to this specific antigen is essential for evaluating vaccine efficacy and understanding the epidemiology of cholera outbreaks.
Induction of protective mucosal and systemic immunity, specifically vibriocidal antibodies that inhibit bacterial colonization and promote pathogen clearance.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vibrio cholerae O1 Ogawa O-antigen (O1 Ogawa OSP).